Cargando…
ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
Pancreatic cancer is one of the most lethal cancers and its prognosis is extremely poor. Clarification of molecular mechanisms and identification of prognostic biomarkers are urgently needed. Though we previously found that LGMN was involved in pancreatic carcinoma progression, the upstream regulati...
Autores principales: | Yan, Qiang, Ni, Chenming, Lin, Yingying, Sun, Xu, Shen, Zhenhua, Zhang, Minjie, Han, Shuwen, Shi, Jiemin, Mao, Jing, Yang, Zhe, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711721/ https://www.ncbi.nlm.nih.gov/pubmed/34966781 http://dx.doi.org/10.3389/fmolb.2021.764900 |
Ejemplares similares
-
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
por: Khan, Safir Ullah, et al.
Publicado: (2023) -
Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021) -
CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus
por: Zhao, Kaikai, et al.
Publicado: (2021) -
Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021) -
SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)